-Translation-

IP_OCS/013/2022

July 21, 2022

Subject

Notification on the registration of the reduction of the Company's registered capital

To

President

The Stock Exchange of Thailand

Whereas the Extraordinary General Meeting of Shareholders No. 1/2022 of Inter Pharma Public Company Limited ("the Company"), held on July 20, 2022, approved reduction of the Company's registered capital in the amount of 19,423,560 Baht from the registered capital of 178,039,755 Baht to 158,616,195 Baht by canceling 38,847,120 unpaid- up ordinary shares with a par value of 0.50 Baht per share, which is the remaining ordinary shares after the allocation to the existing shareholders in proportion to their respective shareholdings (Rights Offering) of 2,387 shares, and remaining from the reserve for the exercise of the warrants to purchase the Company's ordinary shares (IP-W1 ) of 4 ,774 shares and reserve for the capital increase under General Mandate of 38,839,959 shares, and the amendment of the Company's Memorandum of Association article 4, to comply with the reduction of the registered capital.

The Company has registration of the reduction of the Company's registered capital from the registered capital of 178,039,755 Baht to 158,616,195 Baht by canceling 38,847,120 unpaid-up ordinary shares and the amendment of the Company's Memorandum of Association article 4, to comply with the reduction of the registered capital with the Department of Business Development, the Ministry of Commerce, on July 21, 2022.

Please be informed accordingly,

Your Sincerely,

Dr. Trinnawat Thanitnithiphan

Chief Executive Officer

บริษัท อินเตอร์ ฟาร์มา จ(มหาชน)ากัด เลขที่140/9 อาคารไอทีเอฟ ชั้น 9 ถนนสีลม แขวงสุริยวงศ์ เขตบางรัก กรุงเทพมหานคร10500 โทรศัพท์ 02-634-0225 แฟ็ กซ์ 02-634-0135www.interpharma.co.thInter Pharma Public Company Limited 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawongse, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135www.interpharma.co.th

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Inter Pharma pcl published this content on 21 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 July 2022 15:13:05 UTC.